pharmaphorum4d
The invisible burden of RSV on older adults
This lack of testing amplifies the misdiagnosis of RSV, as its symptoms are so similar to other, more common respiratory viruses like flu. A lack of recognition can also be seen in older adults ...
Yahoo11d
What Older Adults Should Know This RSV Season
Oct. 30—(StatePoint) Each year, up to 160,000 older adults living in the United States are hospitalized and as many as 10,000 die due to respiratory syncytial virus (RSV). RSV is a highly ...
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Medical Xpress25d
Study finds RSV vaccine highly effective in protecting older adults against severe disease, hospitalization and death
RSV affects the nose, throat and lungs, causing substantial illness and death among older adults during these seasonal epidemics. In years prior to the availability of an RSV vaccine, an ...
MedPage Today11d
RSV Vaccine 90% Effective in High-Risk Adults, Real-World Study Shows
The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...
Monthly Prescribing Reference6d
RSV Vaccine Linked to Better Outcomes in Older Adults With IBD
Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.
WebMD24d
RSV Vaccine Shows Strong Protection for Older Adults
RSV vaccines for older adults are available from two drugmakers, and the CDC doesn’t recommend one over the other. Pfizer makes Abrysvo, and GSK makes Arexvy. The researchers in this latest ...
infectiousdiseaseadvisor.com7d
Arexvy Looks Promising for RSV Protection in Younger At-Risk and Immunocompromised Adults
Preliminary data were announced from 2 clinical trials evaluating Arexvy in a broader population of adults at increased for RSV disease.